We are live on ! Find out more
SC

Stempoint Capital Portfolio holdings

AUM $522M
1-Year Est. Return 281.95%
This Fund
S&P 500
This Quarter Est. Return
+8.95%
1 Year Est. Return
+281.95%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$312M
AUM Growth
-$2.13M
Cap. Flow
-$1.57M
Cap. Flow %
-0.5%
Top 10 Hldgs %
50%
Holding
82
New
21
Increased
16
Reduced
15
Closed
29

Top Buys

Rank Stock Value
1
MLYS icon
Mineralys Therapeutics
MLYS
+$9.15M
2
LEGN icon
Legend Biotech
LEGN
+$8.75M
3
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$8.75M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$8.52M
5
CNTA
Centessa Pharmaceuticals
CNTA
+$8.52M

Top Sells

Rank Stock Value
1
ROIV icon
Roivant Sciences
ROIV
+$21.4M
2
RVMD icon
Revolution Medicines
RVMD
+$11.3M
3
NUVL
Nuvalent
NUVL
+$9.55M
4
XENE icon
Xenon Pharmaceuticals
XENE
+$9.21M
5
CGON icon
CG Oncology
CGON
+$7.1M

Sector Composition

Rank Sector Weight
1 Healthcare 99.17%
2 Financials 0.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SLDB icon
76
Solid Biosciences
SLDB
$891M
– –
-198,150
Closed -$733K
SLNO
77
DELISTED
Soleno Therapeutics
SLNO
– –
-11,155
Closed -$797K
SWTX
78
DELISTED
SpringWorks Therapeutics
SWTX
– –
-159,305
Closed -$7.03M
SYRE icon
79
Spyre Therapeutics
SYRE
$8.17B
– –
-136,139
Closed -$2.2M
XENE icon
80
Xenon Pharmaceuticals
XENE
$6.47B
– –
-274,633
Closed -$9.21M
BCAX
81
Bicara Therapeutics
BCAX
$1.81B
– –
-47,078
Closed -$613K
SION
82
Sionna Therapeutics
SION
$2.04B
– –
-60,000
Closed -$628K
1 2 3
4

Similar funds

JE
JMAC Enterprises Newtown, Pennsylvania $522M AUM 15.34% 1-Year Est. Return
GS
GWN Securities Palm Beach Gardens, Florida $523M AUM 20.1% 1-Year Est. Return
LT
Legacy Trust Grand Rapids, Michigan $522M AUM 23.56% 1-Year Est. Return
WFA
WestHill Financial Advisors San Rafael, California $523M AUM 15.95% 1-Year Est. Return
TCM
TruNorth Capital Management Kalamazoo, Michigan $522M AUM 14.26% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
ETS
ESL Trust Services Rochester, New York $524M AUM 17.18% 1-Year Est. Return
CM
Conifer Management New York $524M AUM 14.11% 1-Year Est. Return

Stempoint Capital's Q2 2025 Portfolio in Review

As of Q2 2025, Stempoint Capital held 82 positions worth $312M, down 0.68% from $314M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Stempoint Capital's Q2 2025 filing shows 21 new, 16 increased, 15 reduced and 29 closed positions. Its largest new stake was Mineralys Therapeutics: 631,586 shares worth $8.55M. The largest sale was Roivant Sciences, an estimated $21.4M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 99% a quarter earlier, followed by Financials.

  • Stempoint Capital's largest Q2 2025 buy was Mineralys Therapeutics: 631,586 shares worth $8.55M.
  • Stempoint Capital added most to Rhythm Pharmaceuticals in Q2 2025, an estimated $8.75M increase.
  • Stempoint Capital's biggest Q2 2025 reduction was Roivant Sciences, cutting an estimated $21.4M.
  • Stempoint Capital fully exited Revolution Medicines in Q2 2025, selling an estimated $11.3M.
  • Stempoint Capital's ten largest holdings make up 50% of its $312M portfolio in Q2 2025.
  • Stempoint Capital opened 21 new positions and closed 29 in Q2 2025.
  • Stempoint Capital's portfolio value fell 0.68% quarter-over-quarter to $312M.

Based on Stempoint Capital's 13F filing for Q2 2025, filed 14 Aug 2025.